PT1147420E - Inibidor de tripsina urinario para o diagnostico da sida - Google Patents

Inibidor de tripsina urinario para o diagnostico da sida

Info

Publication number
PT1147420E
PT1147420E PT00902627T PT00902627T PT1147420E PT 1147420 E PT1147420 E PT 1147420E PT 00902627 T PT00902627 T PT 00902627T PT 00902627 T PT00902627 T PT 00902627T PT 1147420 E PT1147420 E PT 1147420E
Authority
PT
Portugal
Prior art keywords
urinary
aids diagnosis
inhibitor
tryspin
aids
Prior art date
Application number
PT00902627T
Other languages
English (en)
Inventor
Marina N Papuashvili
Original Assignee
Technologie Integrale Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technologie Integrale Ltd filed Critical Technologie Integrale Ltd
Publication of PT1147420E publication Critical patent/PT1147420E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • AIDS & HIV (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PT00902627T 1999-01-26 2000-01-24 Inibidor de tripsina urinario para o diagnostico da sida PT1147420E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19903034 1999-01-26
DE19920704A DE19920704C1 (de) 1999-01-26 1999-05-05 Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS

Publications (1)

Publication Number Publication Date
PT1147420E true PT1147420E (pt) 2004-12-31

Family

ID=26051490

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00902627T PT1147420E (pt) 1999-01-26 2000-01-24 Inibidor de tripsina urinario para o diagnostico da sida

Country Status (11)

Country Link
US (1) US6242197B1 (pt)
EP (1) EP1147420B1 (pt)
JP (1) JP3534703B2 (pt)
AT (1) ATE271225T1 (pt)
AU (1) AU770114B2 (pt)
CA (1) CA2361000C (pt)
DE (2) DE19920704C1 (pt)
DK (1) DK1147420T3 (pt)
ES (1) ES2225081T3 (pt)
PT (1) PT1147420E (pt)
WO (1) WO2000045175A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2832155B1 (fr) * 2001-11-09 2004-07-09 Lab Francais Du Fractionnement Anticorps stimulant la production d'il-1ra
WO2005040222A1 (en) * 2003-10-16 2005-05-06 Bayer Healthcare Llc Monoclonal antibodies for detection of urinary trypsin inhibitors
ES2625406T3 (es) 2010-03-25 2017-07-19 Oregon Health & Science University Glicoproteínas de CMV y vectores recombinantes
SI2691530T1 (en) 2011-06-10 2018-08-31 Oregon Health & Science University CMV glycoproteins and recombinant vectors
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9925258B2 (en) 2015-10-02 2018-03-27 International Aids Vaccine Initiative Replication-competent VSV-HIV Env vaccines
US11725043B2 (en) 2020-03-05 2023-08-15 DiaMedica USA Inc. Ulinastatin polypeptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2804979B2 (ja) * 1988-11-28 1998-09-30 日本ケミカルリサーチ株式会社 エイズ治療および阻害剤
JPH05304983A (ja) * 1992-04-27 1993-11-19 Nissin Food Prod Co Ltd ヒト尿中蛋白質分解酵素阻害蛋白質の定量のための物質および定量方法

Also Published As

Publication number Publication date
EP1147420A1 (en) 2001-10-24
JP2002535679A (ja) 2002-10-22
DE19920704C1 (de) 2000-08-31
AU2439600A (en) 2000-08-18
ATE271225T1 (de) 2004-07-15
US6242197B1 (en) 2001-06-05
CA2361000C (en) 2009-12-22
ES2225081T3 (es) 2005-03-16
DK1147420T3 (da) 2004-11-29
WO2000045175A1 (en) 2000-08-03
AU770114B2 (en) 2004-02-12
EP1147420B1 (en) 2004-07-14
DE60012140D1 (de) 2004-08-19
DE60012140T2 (de) 2005-09-08
CA2361000A1 (en) 2000-08-03
JP3534703B2 (ja) 2004-06-07

Similar Documents

Publication Publication Date Title
BR0317715A (pt) Composições e processos de uso de collajolie
PT1147420E (pt) Inibidor de tripsina urinario para o diagnostico da sida
EA200200118A1 (ru) β-КАРБОЛИНОВЫЕ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
ECSP045520A (es) Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos
DK1268847T3 (da) Ubiquitin-ligaseassay
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
CY1107531T1 (el) Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου
ATE445389T1 (de) Liposomale glucocorticoide
HN2001000217A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa - 7
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
PT1473036E (pt) Solvato de hemitartarato de zolpidem
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
BR9809848A (pt) Composição
TR199800841A2 (xx) �kame edilmi� 6- ve 7-aminotetrahidroisokinolinkarbon asitleri.
WO2003084384A3 (en) Diagnosis of flavivirus infection
DE60025494D1 (de) Epothilon zusammensetzungen
ES2186807T3 (es) Inhibidores de trombina.
BR9808923B1 (pt) processos para fazer compostos inibidores de ciclooxigenase-2, e, compostos intermediÁrios para fazer inibidores de ciclooxigenase-2.
BR0110902A (pt) Inibidores de mmp-9/mmp-2
DE69930844D1 (de) Inhibitoren von mycobakterien
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
DE60201440D1 (de) Aryl-8-azabicyclo[3.2.1]octanes für die behandlung von depression
NO995849D0 (no) Aldehydfritt desinfeksjonsmiddel for overflater og instrumenter
ES2186782T3 (es) Uso de derivados de tropolona como inhibidores de la enzima inositol-monofosfatasa.
PT1313500E (pt) Associacoes de dalfopristina/quinupristina com o cefpirome